Cannabis products made from extracts – including concentrates, vapes, edibles, topicals and tinctures – account for 57% of legal cannabis sales in the U.S. so far in 2020.
The vaping scare shook up the concentrates market in the second half of 2019, but despite last year’s upheaval, the sales and popularity of extracted products continues to grow nationally, according to research from cannabis analytics firms BDSA, Brightfield Group and New Frontier Data.
While flower remains the top-selling category of cannabis products across the country, concentrates are taking up a larger and larger part of the market, both in individual states and the national market as a whole.
According to New Frontier Data, cannabis products made from extracts — including concentrates, vapes, edibles, topicals and tinctures — account for 57% of legal cannabis sales in the United States so far in 2020. New Frontier projects that products made from extracts will represent about $10.2 billion of the $18 billion in total legal cannabis sales expected this year.